ABSTRACT
ABSTRACT Objective: To investigate whether there is an association between suicidal ideation (SI) and allergic diseases in adults. Methods: This was a comparative cross-sectional study involving individuals ranging from 20 to 50 years of age recruited from a university hospital in the city of Guadalajara, Mexico. We included patients with a confirmed diagnosis of allergic asthma, those with a confirmed diagnosis of allergic rhinitis, and healthy controls. All subjects completed the Beck Depression Inventory-II (BDI-II), which includes an item that evaluates the presence of suicidal thoughts or desires within the last two weeks, in order to identify SI. Results: The sample comprised 115 patients with allergic asthma, 111 patients with allergic rhinitis, and 96 healthy controls. The number of individuals identified with SI in the three groups were, respectively, 17 (14.8%), 13 (11.7%), and 8 (8.3%). Regarding the presence of SI, no statistically significant association was found in the allergic asthma group (OR = 1.98; 95% CI: 0.78-4.64; p = 0.154) or in the allergic rhinitis group (OR = 1.46; 95% CI: 0.58-3.68; p = 0.424) when they were compared with the control group. However, the presence of depression was associated with SI in the three groups: allergic asthma (OR = 12.36; 95% CI: 2.67-57.15; p = 0.001); allergic rhinitis (OR = 6.20; 95% CI: 1.66-23.14; p = 0.006); and control (OR = 21.0; 95% CI: 3.75-117.36; p < 0,001). Conclusions: In comparison with the control group, no association was found between SI and the groups with allergic diseases. In contrast, there was association between SI and depression in the three groups.
RESUMO Objetivo: Investigar se existe associação entre ideação suicida (IS) e doenças alérgicas em adultos. Métodos: Estudo transversal comparativo envolvendo indivíduos com idade entre 20 e 50 anos recrutados em um hospital universitário da cidade de Guadalajara, México. Foram incluídos pacientes com diagnóstico confirmado de asma alérgica, aqueles com diagnóstico confirmado de rinite alérgica e controles saudáveis. Todos os sujeitos preencheram o Beck Depression Inventory-II (BDI-II), que inclui um item que avalia a presença de pensamentos ou desejos suicidas nas últimas duas semanas, a fim de identificar IS. Resultados: A amostra foi composta por 115 pacientes com asma alérgica, 111 pacientes com rinite alérgica e 96 controles saudáveis. O número de indivíduos identificados com IS nos três grupos foi de 17 (14,8%), 13 (11,7%) e 8 (8,3%), respectivamente. Quanto à presença de IS, não foi encontrada associação estatisticamente significativa no grupo asma alérgica (OR = 1,98; IC95%: 0,78-4,64; p = 0,154) ou no grupo rinite alérgica (OR = 1,46; IC95%: 0,58-3,68; p = 0,424) quando os mesmos foram comparados com o grupo controle. No entanto, a presença de depressão apresentou associação com IS nos três grupos: asma alérgica (OR = 12,36; IC95%: 2,67-57,15; p = 0,001); rinite alérgica (OR = 6,20; IC95%: 1,66-23,14; p = 0,006); e controle (OR = 21,0; IC95%: 3,75-117,36; p < 0,001). Conclusões: Em comparação com o grupo controle, não foi encontrada associação entre IS e os grupos com doenças alérgicas. Por outro lado, houve associação entre IS e depressão nos três grupos.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Asthma/psychology , Depressive Disorder/psychology , Suicidal Ideation , Rhinitis, Allergic/psychology , Psychiatric Status Rating Scales , Severity of Illness Index , Cross-Sectional Studies , Risk FactorsABSTRACT
Introducción. Como sucede en otras partes del mundo, la prevalencia de asma y rinitis alérgica en Colombia está en aumento. Se ha establecido que la inmunoterapia subcutánea con alérgenos es eficaz a largo plazo en pacientes con rinitis alérgica y asma sensibilizados a Dermophagoides. Objetivo. Proveer evidencia sobre los cambios relacionados con la calidad de vida inducidos por la inmunoterapia subcutánea en sujetos con alergia respiratoria. Materiales y métodos. Se seleccionaron 76 sujetos con diagnóstico de alergia respiratoria con sensibilización a Dermatophagoides farinae y Dermatophagoides pteronyssinus . Para la evaluación de la calidad de vida se emplearon los instrumentos Kidscreen-27 y SF-36 ( Short form 36 ). Estos instrumentos se aplicaron en dos ocasiones: durante la primera visita, en la cual se iniciaba la inmunoterapia subcutánea, y un año después de haberse iniciado el tratamiento. Resultados. Al año de estar recibiendo la inmunoterapia, los 22 sujetos que completaron el estudio presentaron cambios positivos en términos de calidad de vida. En los niños, el principal cambio se presentó en el dominio del ´entorno escolar´ mientras que en los adultos fue en el de la ´función física´ . Discusión. Se evaluaron por primera vez en Colombia los beneficios inducidos por la inmunoterapia subcutánea para ácaros de polvo en la calidad de vida de sujetos con rinitis alérgica y asma mediante los cuestionarios Kidscreen-27 y SF-36. Los resultados proveen evidencia de que la inmunoterapia subcutánea influye positivamente en la calidad de vida en sujetos con rinitis asmática y asma sensibilizados a los ácaros de polvo.
Introduction: The prevalence of asthma and allergic rhinitis in Colombia is increasing at the same rate as it is in other parts of the world. It has been determined that allergen-specific subcutaneous immunotherapy is effective in subjects with allergic rhinitis and asthma that are sensitized to house dust mites: Dermatophagoides farinae and Dermatophagoides pteronyssinus . Objective: To provide evidence on changes in the quality of life of subjects induced by allergen-specific subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus . Materials and methods: We selected 76 subjects with a diagnosis of respiratory allergy with sensitization to Dermatophagoides farinae and Dermatophagoides pteronyssinus . The instruments used for evaluating the quality of life were Kidscreen-27 and SF-36. These instruments were applied twice for each subject: once during the first visit, and during the twelfth visit corresponding to the one-year follow-up. Results: Twenty-two subjects completed this study. After one year of treatment with allergen-specific subcutaneous immunotherapy, we found positive changes in terms of the quality of life. In children, the main change was in the School Environment domain while in adults it was in the Physical Function domain. Conclusion: We evaluated, for the first time in Colombia, benefits induced by allergen-specific subcutaneous immunotherapy for dust mites in terms of quality of life in subjects with allergic rhinitis and asthma. These results demonstrated that allergen-specific subcutaneous immunotherapy produces a positive influence on subjects sensitized to dust mites that received allergen-specific subcutaneous immunotherapy to Dermatophagoides farinae and Dermatophagoides pteronyssinus after one year.